FY25 consensus $547.64M. FY25: GAAP net income (loss) is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million. Adjusted EBITDA is expected to be in the range of $80 million to $95 million, compared to the prior range of $60 million to $80 million. Operating cash flow is expected to be in the range of (25M) to $0 million, compared to the prior range of (25M) to $10.0 million. The above guidance includes the impact of positive net adjustment revenue which is expected to be in the range of $40 million to $45 million, compared to the previous range of $40 million to $43 million.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHTH:
- Cautious Optimism: Hold Rating for eHealth Amidst Stabilization and Risks
- eHealth price target lowered to $9 from $10 at RBC Capital
- eHealth price target lowered to $8 from $10 at Deutsche Bank
- EHealth Inc. Earnings Call: Mixed Sentiment, Optimistic Guidance
- Ehealth: Hold Rating Amidst Declining Revenue and Strategic Adjustments